GSDME and neoplasm: TMAO can induce gasdermin E (GSDME)-mediated tumor cell pyroptosis by activating the endoplasmic reticulum kinase PERK, leading to release inflammatory factors such as IL-1β and IL-18 into the tumor microenvironment (Fig. 3B).